Phl p 1 Recombinant Antibody [Clone 25] (OAAV00853)

Produktübersicht

• Artikelname: Phl p 1 Recombinant Antibody [Clone 25] (OAAV00853)
• Artikelnummer: ASB-OAAV00853
• Hersteller Artikelnummer: OAAV00853
• Alternativnummer: ASB-OAAV00853-200UG
• Hersteller: Aviva
• Wirt: Human
• Kategorie: Proteine/Peptide
• Applikation: Blocking, FC, IP
• Spezies Reaktivität: Human, Primate
• Immunogen: This antibody was prepared by the humanization of LL2 (EPB-2), a murine anti-CD22 IgG2a raised against Raji Burkitt lymphoma cells. Murine sequences comprise 5-10% of the molecule, with the remainder being human framework sequences, which greatly reduces the potential for immunogenicity (Traczewski, 2010).
• Alternative Synonym: B-cell receptor CD22,BL-CAM,B-lymphocyte cell adhesion molecule,CD22 antigen,sialic acid-binding Ig-like lectin 2,SIGLEC2,SIGLEC-2,T-cell surface antigen Leu-14.

Produkteigenschaften

• Klonalität: Monoclonal
• Klon-Bezeichnung: [hL22 Epratuzumab]
• NCBI: 933
• Formulierung: PBS with 0.02% Proclin 300.

Anwendungsbeschreibung

• Application Verdünnung: Mediates B-cell B-cell interactions. May be involved in the localization of B-cells in lymphoid tissues. Binds sialylated glycoproteins, one of which is CD45. Preferentially binds to alpha-2,6-linked sialic acid. The sialic acid recognition site can be ma